• linkedin
  • Increase Font
  • Sharebar

    DOJ charges group for generating bogus scripts and cheating government and private insurers


     “Corrupt co-conspirator physicians issued prescriptions for compounded medications to patients regardless of medical necessity and in exchange for illegal compensation, “such as cash, gift cards, and free consulting,” according to the information, which also described small payments to patients.

    Payments were often disguised as reimbursement for “data collection” and were distributed through a sham software company called ClinicalCorp LLC, prosecutors said. Other companies that participated were NuMedCare LLC, which purportedly supplied management services to pharmacies, and two failing compounders: Rx of Boca LLC and Dallas-based Texas Compounding Pharmacy.

    NuMed eventually was advised by in-house counsel that its conduct was illegal, and the counsel “continued to assist. . .  in the operation of NuMed by providing legal advice and the preparation of legal documents to conceal and disguise the criminal activity.”

    [The U.S. is represented by Wifredo A. Ferrer, Paul F. Schwartz and Jeffrey Kaplan of the DOJ. Counsel information for the defendants was not immediately available. The case is U.S. v. Carroll et al., case number 0:16-cr-60227, in the U.S. District Court for the Southern District of Florida.]

    Ned Milenkovich is co-chair of the Health Law practice at Much Sehlist PC and vice chair of the Illinois State Board of Pharmacy. Contact him at 312-521-2482 or at [email protected]

    Ned Milenkovich, PharmD, JD
    This article is not intended as legal advice and should not be used as such. When legal questions arise, pharmacists should consult with ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available